Profile
Aaron Foster served as Senior Vice President & Head-Research at Bellicum Pharmaceuticals, Inc. and as Assistant Professor-Center for Cell & Gene Therapy at Baylor College of Medicine.
Prior to that, he received an undergraduate degree from the University of Puget Sound in 1994 and a doctorate degree from The University of Sydney in 2003.
Former positions of Aaron Foster
| Companies | Position | End |
|---|---|---|
| Baylor College of Medicine | Corporate Officer/Principal | 01/01/2012 |
| BELLICUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Aaron Foster
| University of Puget Sound | Undergraduate Degree |
| The University of Sydney | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Aaron Foster
